These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Conversion from +Sandimmune to Neoral in kidney transplant recipients treated with cyclosporine and ketoconazole]. Videla C; Vega J; Borja H; Gatica A; Clavero R; Aldunate T Rev Med Chil; 1997 Apr; 125(4):438-45. PubMed ID: 9460285 [TBL] [Abstract][Full Text] [Related]
3. Effect of ketoconazole on cyclosporine dose in healthy dogs. Dahlinger J; Gregory C; Bea J Vet Surg; 1998; 27(1):64-8. PubMed ID: 9449179 [TBL] [Abstract][Full Text] [Related]
4. Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole. Jeng S; Chanchairujira T; Jusko W; Steiner R Transplantation; 2003 Mar; 75(6):792-5. PubMed ID: 12660503 [TBL] [Abstract][Full Text] [Related]
5. Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients. Sugioka N; Kokuhu T; Okamoto M; Yoshimura N; Ito Y; Shibata N; Takada K J Pharm Pharmacol; 2006 Sep; 58(9):1193-200. PubMed ID: 16945177 [TBL] [Abstract][Full Text] [Related]
6. [Combination of cyclosporin and ketoconazole in immunosuppression schemes in patients with transplanted kidney]. Treĭvish VS; Shoĭkhet IN; Ankova EV Klin Med (Mosk); 1998; 76(1):40-2. PubMed ID: 9532915 [TBL] [Abstract][Full Text] [Related]
7. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters. Takeuchi H; Okuyama K; Konno O; Jojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Uchiyama M; Ashizawa T; Matsuno N; Nagao T; Hirano T; Oka K Transplant Proc; 2005 May; 37(4):1745-7. PubMed ID: 15919452 [TBL] [Abstract][Full Text] [Related]
8. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function. Qazi YA; Forrest A; Tornatore K; Venuto RC Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine trough levels in renal graft recipients. Jauhari H; Wadhawan S; Yashpal ; Kumar A J Indian Med Assoc; 1999 Nov; 97(11):476-7. PubMed ID: 10638120 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
16. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation. Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636 [TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity associated with cyclosporine monitoring using C2 recommendations in adults renal recipients receiving ketoconazole. Videla C; Vega J; Borja H Transplant Proc; 2005 Apr; 37(3):1574-6. PubMed ID: 15866677 [TBL] [Abstract][Full Text] [Related]